Showing 1841-1850 of 3890 results for "".
Professionalism and Board Certification in Dermatology
https://practicaldermatology.com/topics/practice-management/professionalism-and-board-certification-in-dermatology/23706/Lead from Ahead (For a Change)
https://practicaldermatology.com/topics/practice-management/lead-from-ahead-for-a-change/23973/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Optimizing Wound Healing for Cosmetic and Medical Dermatologic Procedures
https://practicaldermatology.com/topics/practice-management/optimizing-wound-healing-for-cosmetic-and-medical-dermatologic-procedures/20522/Among the options for wound management is hypochlorous acid, a broad-action antimicrobial and anti-inflammatory agent.Diagnosing and Managing Acne in Pre-Adolescent and Adolescent Patients
https://practicaldermatology.com/issues/supplements/diagnosing-and-managing-acne-in-pre-adolescent-and-adolescent-patients/23418/How to overcome challenges to effective care.Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/issues/supplements/exploring-the-connection-between-gut-health-and-hair/23089/Sponsored by Nutrafol®Inside Cosmeceutical Marketing Claims
https://practicaldermatology.com/topics/general-topics/inside-cosmeceutical-marketing-claims/21642/Dermatologists and their patients may wonder what makes a product “dermatologist tested” or “clinically proven.” Here's what you need to know.Approvals in Psoriasis and Skin Cancer Highlight a Year of Innovation in Skin Disease Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approvals-in-psoriasis-and-skin-cancer-highlight-a-year-of-innovation-in-skin-disease-management/21069/After periods of low drug approval rates, the last year brought several new agents to market.AI and Skin of Color: Hidden Biases Raise Questions
https://practicaldermatology.com/topics/skin-of-color/ai-and-skin-of-color-hidden-biases-raise-questions/23994/AI holds potential for practitioners, but it’s important to think critically about what data we use to build models.Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/